1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Immunohistochemistry Market
2.2. Global Immunohistochemistry Market, By Product, 2023 (US$ Million)
2.3. Global Immunohistochemistry Market, By Application, 2023 (US$ Million)
2.4. Global Immunohistochemistry Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Immunohistochemistry Market: Competitive Analysis
3.1. Market Positioning of Key Immunohistochemistry Market Vendors
3.2. Strategies Adopted by Immunohistochemistry Market Vendors
3.3. Key Industry Strategies
4. Immunohistochemistry Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Immunohistochemistry Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Antibodies
5.3.1.1. Primary Antibodies
5.3.1.2. Secondary Antibodies
5.3.2. Equipment
5.3.2.1. Slide Staining Systems
5.3.2.2. Tissue Microarrays
5.3.2.3. Tissue Processing Systems
5.3.2.4. Slide Scanners
5.3.2.5. Others
5.3.3. Reagents
5.3.3.1. Histological Stains
5.3.3.2. Blocking Sera and Reagents
5.3.3.3. Chromogenic Substrates
5.3.3.4. Fixation Reagents
5.3.3.5. Stabilizers
5.3.3.6. Organic Solvents
5.3.3.7. Proteolytic Enzymes
5.3.3.8. Diluents
5.3.4. Kits

6. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Diagnostics
6.3.1.1. Cancer
6.3.1.2. Infectious Diseases
6.3.1.3. Cardiovascular Diseases
6.3.1.4. Autoimmune Diseases
6.3.1.5. Diabetes Mellitus
6.3.1.6. Nephrological Diseases
6.3.2. Drug Testing


7. North America Immunohistochemistry Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
7.3. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
7.4.Immunohistochemistry Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Immunohistochemistry Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.3. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.Immunohistochemistry Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Immunohistochemistry Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.3. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.Immunohistochemistry Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)

10. Latin America Immunohistochemistry Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
10.3. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
10.4.Immunohistochemistry Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Immunohistochemistry Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
11.3. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
11.4.Immunohistochemistry Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Immunohistochemistry Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Immunohistochemistry Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Abcam plc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. BioSB
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Cell Signaling Technology, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Danaher Corporation
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. F.Hoffman La-Roche Ltd
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Merck Millipore Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Perkin Elmer, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Other Notable Players
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives